ASX Runners of the Week: Bio-Gene, Alterity, Aston & Canterbury

Clinical OMICsAdvanced Cardiovascular-Kidney-Metabolic Syndrome Linked to Increased Cancer Risk

BioPharma DiveBayer to buy Perfuse for up to $2.45B, bolstering eye drug pipeline

Thermo FisherThermo Fisher Scientific’s Clinical Research Business Named a Leader Among CROs in 2026 ISG Provider - PharmiWeb.com

BioPharma DiveNovo hikes guidance on Wegovy pill’s fast sales start

Endpoints NewsMadrigal's Rezdiffra beats estimates; Gilead cuts jobs; Banyan debuts

Endpoints NewsFormer Orbital scientists launch new mRNA therapy startup

FierceBiotechBioCryst scraps eye candidate to focus on rare diseases

Clinical OMICsNext Generation CRISPR Gene Editing Could Help Target Cancer Cells

Endpoints NewsAvalo scores Phase 2 success in comeback bid, raises $375M

BioPharma DiveAvalo shares spike on skin drug data; BioNTech to cut staff

Promega BlogA Historic Milestone for PROTAC Research: What Vepdegestrant’s FDA Decision Means for Drug Discovery

Clinical OMICsMatthew Rabinowitz: Engineering a New Era of Diagnosis